Pineapple Express Cannabis (PNXP) Liabilities and Shareholders Equity (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Liabilities and Shareholders Equity came in at $190000.0 in Q4 2025, down 93.7% year-on-year from $3.0 million in Q4 2024, and little changed quarter-over-quarter from $190000.0 in Q3 2025.
Pineapple Express Cannabis (PNXP) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $190000.0 for Q4 2025.
- Liabilities and Shareholders Equity for Q4 2025 came in at $190000.0, down 93.7% year-over-year; the trailing twelve-month figure through Oct 2025 was $570000.0 (down 94.83% YoY), and the FY2024 annual result was $1870.0, down 18.7% from the prior year.
- Liabilities and Shareholders Equity came in at $190000.0 for Q4 2025 at Pineapple Express Cannabis, roughly flat from $190000.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $5.0 million in Q2 2024 to a low of $1870.0 in Q1 2024.
- The 5-year median for Liabilities and Shareholders Equity is $32322.0 (2021), against an average of $741529.6.
- Across the five-year window, Liabilities and Shareholders Equity soared 10109.59% in 2023 and slumped 96.2% in 2025, its largest moves.
- Pineapple Express Cannabis' Liabilities and Shareholders Equity stood at $18510.0 in 2021, then slumped by 43.06% to $10539.0 in 2022, then jumped by 10109.59% to $1.1 million in 2023, then surged by 180.37% to $3.0 million in 2024, then sank by 93.7% to $190000.0 in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $190000.0 (Q4 2025), $190000.0 (Q3 2025), and $190000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.27 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.35 Bn |
| 10 | Pineapple Express Cannabis | - | - | - | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 190,000.00 |
| Jul 31, 2025 | 190,000.00 |
| Apr 30, 2025 | 190,000.00 |
| Oct 31, 2024 | 3.02 Mn |
| Jul 31, 2024 | 3.01 Mn |
| Apr 30, 2024 | 5.00 Mn |
| Jan 31, 2024 | 1,870.00 |
| Oct 31, 2023 | 1.08 Mn |
| Jul 31, 2023 | 934,828.00 |
| Apr 30, 2023 | 324,445.00 |
| Jan 31, 2023 | 2,300.00 |
| Oct 31, 2022 | 10,539.00 |
| Jul 31, 2022 | 11,110.00 |
| Apr 30, 2022 | 12,354.00 |
| Jan 31, 2022 | 18,209.00 |
| Oct 31, 2021 | 18,510.00 |
| Jul 31, 2021 | 19,537.00 |
| Apr 30, 2021 | 25,180.00 |
| Jan 31, 2021 | 32,322.00 |
| Oct 31, 2020 | -22,329.00 |